Mettler-Toledo International, Inc. (NYSE:MTD) Holdings Trimmed by Impax Asset Management Group plc

Impax Asset Management Group plc lowered its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 3.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 191,467 shares of the medical instruments supplier’s stock after selling 7,385 shares during the quarter. Mettler-Toledo International accounts for approximately 1.4% of Impax Asset Management Group plc’s investment portfolio, making the stock its 20th largest position. Impax Asset Management Group plc owned approximately 0.92% of Mettler-Toledo International worth $226,105,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of MTD. SRS Capital Advisors Inc. boosted its stake in Mettler-Toledo International by 43.8% during the fourth quarter. SRS Capital Advisors Inc. now owns 69 shares of the medical instruments supplier’s stock valued at $84,000 after buying an additional 21 shares in the last quarter. Jones Financial Companies Lllp boosted its stake in Mettler-Toledo International by 54.9% during the fourth quarter. Jones Financial Companies Lllp now owns 175 shares of the medical instruments supplier’s stock valued at $214,000 after buying an additional 62 shares in the last quarter. SBI Securities Co. Ltd. acquired a new position in shares of Mettler-Toledo International in the 4th quarter valued at $33,000. Steward Partners Investment Advisory LLC boosted its position in shares of Mettler-Toledo International by 3.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier’s stock valued at $374,000 after purchasing an additional 9 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Mettler-Toledo International by 1.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 141,263 shares of the medical instruments supplier’s stock valued at $172,861,000 after purchasing an additional 2,262 shares during the period. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

MTD opened at $1,209.08 on Friday. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The business has a 50-day moving average of $1,150.84 and a 200-day moving average of $1,196.01. The company has a market capitalization of $25.12 billion, a PE ratio of 30.15, a price-to-earnings-growth ratio of 3.72 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, topping analysts’ consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The company had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. During the same period last year, the business earned $8.89 EPS. The business’s quarterly revenue was down 4.6% on a year-over-year basis. On average, equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MTD has been the subject of a number of recent analyst reports. Wells Fargo & Company increased their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an “equal weight” rating in a research report on Monday, May 5th. Jefferies Financial Group upgraded Mettler-Toledo International from an “underperform” rating to a “hold” rating and decreased their price target for the company from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. UBS Group upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and decreased their price target for the company from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Wall Street Zen lowered Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Monday, May 5th. Finally, Citigroup raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price objective for the company in a research note on Monday, April 7th. Eight investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,300.36.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the transaction, the director owned 120 shares of the company’s stock, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.94% of the stock is owned by company insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.